Zscaler, Inc. (ZS)
Live price chart, market sentiment, and community perspectives for Zscaler, Inc. (NASDAQ: ZS).
Live price chart, market sentiment, and community perspectives for Zscaler, Inc. (NASDAQ: ZS).
On our fundamental desk, Zscaler's recent 31% post-earnings drop underscores a classic multiple contraction event. Even though Q3 results beat top and bottom lines, management's preliminary fiscal 2027 revenue and ARR guidance of 16% to 17% shocked investors who expected closer to 20%. When compared to stellar performers like CrowdStrike and Palo Alto Networks, Zscaler's deceleration makes it a laggard in the broader Zacks Security industry.
Looking at the options flow and risk metrics on ZS, the fundamental disconnect is stark. Wall Street maintains 38 buy ratings against zero sells, yet retail sentiment on platforms like Reddit and X lingers around a meager 42% bullishness. The sudden cut to free-cash-flow margin guidance driven by higher planned capital expenditures has introduced a fresh overhang, triggering 52-week lows and leaving the stock vulnerable to further tech-sector pullbacks and insider selling pressure.
When evaluating Zscaler's operational efficiency for growth modeling, analysts must weigh the record $3.525 billion in annual recurring revenue against the stark reality of decelerating forward metrics. Management explicitly guided total ARR and revenue growth down for fiscal 2027. Interviewees and candidates discussing ZS must emphasize that headline beats no longer shield a cloud security vendor when forward guidance resets downward.
As a hedge fund portfolio manager tracking software-infrastructure equities, ZS has been a major disappointment, plunging over 50% in a year while peers rally over 45%. The market is punishing any company signaling even mild friction in capital efficiency or free cash flow. Until management proves that their 16%-17% ARR growth forecast is conservative rather than structural, institutional accumulation will likely remain sidelined.
From a quantitative risk management perspective, Zscaler's sharp selloff following the Q3 earnings release highlights the severe cost of lower-than-anticipated Q4 revenue guidance ($875M-$878M vs. $879M consensus). Coupled with a reduced free-cash-flow margin profile and recent insider sale filings, the equity risk premium for ZS has spiked, keeping short-term volatility elevated relative to its historical beta.
Explore plasma cleansing, somatic organ swaps, and BCI.